Panibon, Vicenta .
HRN: 02-17-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/13/2023
10/19/2023
IV
2.25
Q8
Cholecystitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes